| 000 | 01036 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250517213104.0 | ||
| 264 | 0 | _c20181102 | |
| 008 | 201811s 0 0 eng d | ||
| 022 | _a0035-3787 | ||
| 024 | 7 |
_a10.1016/j.neurol.2017.09.013 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVitturi, B K | |
| 245 | 0 | 0 |
_aMetronidazole-induced encephalopathy. _h[electronic resource] |
| 260 |
_bRevue neurologique _cMay 2018 |
||
| 300 |
_a342-343 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntitrichomonal Agents _xadverse effects |
| 650 | 0 | 4 |
_aBrain Diseases _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetronidazole _xadverse effects |
| 700 | 1 | _ada Silva Júnior, R G | |
| 700 | 1 | _ada Rocha, A J | |
| 700 | 1 | _aNarimatsu, K | |
| 773 | 0 |
_tRevue neurologique _gvol. 174 _gno. 5 _gp. 342-343 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.neurol.2017.09.013 _zAvailable from publisher's website |
| 999 |
_c28330908 _d28330908 |
||